JDJames N. Dodds

James N. Dodds

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


James N. Dodds has a total of 140 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Integrating Computational Chemistry and Ion Mobility Spectrometry into Non-Targeted Analysis Workflows for the Structural Elucidation of Emerging PFAS

    by Allison N. Fry, Christian Ieritano, W. Scott Hopkins, P. B. Armentrout, James N. Dodds, Erin S. Baker

    Per- and polyfluoroalkyl substances (PFAS) are an evolving class of synthetic chemicals that are pervasive in the environment due to widespread manufacturing and consumer use, such that PFAS contamination is of great concern. Although thousands of PFAS structures have been reported to date, this number increases daily with the identification of new PFAS from advances in non-targeted analysis (NTA) workflows. Ion mobility spectrometry in combination with mass spectrometry (IMS-MS) has recently been incorporated into PFAS NTA studies. Although MS provides essential precursor and fragmentation data, IMS offers complementary structural information via the measurement of the ion-neutral collision cross section (CCS) values. Experimental CCS values can then be compared with those calculated in silico from candidate 3D structures to meet confidence-level criteria in analyte assignments within NTA workflows. Although this approach has been applied since the late 1990s, PFAS often exhibited poorer agreement between the calculated and experimental CCS values. To address this limitation, we propose an optimized computational workflow to calculate Boltzmann-weighted CCS values for PFAS structures generated via quantum-chemical calculations. This workflow was assessed with experimental CCS values from 56 known PFAS structures across seven classes and resulted in an average percent error of 2.0%. Moreover, 11 new PFAS structures were proposed from NTA, with average errors of 1.3%. The combination of this new computational workflow and experimental IMS-MS measurements therefore establishes a workflow for structural elucidation of emerging PFAS.

  • Uncovering PFAS and halogenated chemicals using nontargeted analysis and the PFAS IMplementer for mass spectrometry (PIMMS)

    by Gregory P. Kudzin, James N. Dodds, Erin S. Baker

    Per- and polyfluoroalkyl substances (PFASs) are synthetic chemicals of considerable epidemiological concern. While targeted liquid chromatography (LC)–tandem mass spectrometry (MS/MS) methods are established for legacy PFAS, emerging replacement compounds require nontargeted analysis (NTA) for comprehensive characterization. However, NTA of complex biological matrices like human serum is analytically challenging because of the presence of many endogenous interferences and unknown PFAS molecules. To address this, ion mobility spectrometry has been coupled with LC and MS (LC-IMS-MS). This approach provides orthogonal separation via collision cross section to resolve isobars and filter noise. Despite its utility, current software lacks efficient PFAS feature prioritization, requiring extensive manual curation. We developed the PFAS IMplementer for Mass Spectrometry (PIMMS), a vendor-neutral, open-source tool that uses advanced filtering and scoring algorithms for rapid LC-IMS-MS data analysis. The potential utility of PIMMS was demonstrated using serum from bovine and human populations. PIMMS could identify both legacy and novel PFAS in addition to eight halogenoalkane xenobiotics (containing bromine, chlorine, and iodine). Of note, these halogenoalkane species were often only singly or doubly halogenated and were still effectively prioritized by PIMMS demonstrating the potential to identify a potentially growing number of novel compounds with only a single degree of halogenation.


  • Mood Altering Waters: Multidimensional Profiling and Chiral Characterization of Antidepressants in Effluent-Impacted Waterways

    by Emily C. Vincent, Mark W. Sumarah, Justin B. Renaud, Natasha DesRochers, Haley C. Jostes, Allison N. Fry, Jack P. Ryan, James N. Dodds, Jian Zhang, Paul A. Thiessen, et al.

    Antidepressants (ADs) and their metabolites are widely reported in wastewater effluent and effluent-impacted waterways due to incomplete removal during wastewater treatment. These chemicals have been known to influence the behavior and physiology of exposed organisms, raising concerns regarding the ecological impact of this contamination. However, although 28 ADs are approved by the United States Food and Drug Administration, environmental studies commonly target only a small fraction of these chemicals, as conventional analytical approaches are hindered by coeluting isomers and structural similarity. Here, we developed a multidimensional workflow integrating liquid chromatography, drift tube ion mobility spectrometry, mass spectrometry, and fragmentation analysis to enable high-confidence identification and targeted quantification of 26 parent and 8 AD metabolites in environmental samples, while also establishing a publicly available reference library to support future studies. Selected compounds were further characterized with chiral chromatography to assess enantiomeric ADs with differing biological activity. This workflow was applied to effluent-impacted waterways, enabling the identification and quantification of 17 AD chemicals across five sites. These findings highlight the prevalence of AD contamination and the need for improved monitoring and wastewater treatment strategies to mitigate ecological and human health risks.


  • Open Access

    Insights into complementary exposomic targeted analysis and suspect screening approaches: a case study examining human serum for chemicals with LC-IMS-MS

    by James N. Dodds, Nikki Barlow, Kara M. Joseph, Sarah J. Rehm, Weihsueh A. Chiu, Gang Han, Yu-Syuan Luo, Kangmin Zhu, Warren Casey, Ivan Rusyn, et al.

    Although PFAS exposure is widespread in the general population, concern is heightened for individuals with unique occupational exposure scenarios. Accordingly, the PROject for Military Exposures and Toxin History Evaluation in US service members (PROMETHEUS) study is evaluating whether serum chemical exposure profiles correlate with cancer incidence in large cohorts (typically hundreds of samples per analysis) among military service members who may experience distinct occupational and environmental exposures. Here we describe analytical workflow development and results from a pilot subset (n = 36) of human serum samples using an integrated targeted and suspect-screening LC-IMS-MS platform. Serum (50 µL) was extracted by acid-assisted protein precipitation with isotopically labeled internal standards, concentrated, and analyzed by LC coupled to an Agilent 6560 IM-QTOF. Targeted PFAS quantitation was performed using matrix-matched calibration curves and was benchmarked against NIST SRM 1957 to assess method accuracy. Across the samples, the targeted panel captured predominantly legacy PFAS as anticipated noting their prevalence in prior studies (e.g., PFOS, PFOA, 8 : 2 FTS, N-MeFOSAA, etc.). Ultra-short-chain PFAS presented class-specific analytical challenges; trifluoromethanesulfonic acid (TFMS) was observed, whereas trifluoroacetic acid (TFA) eluted near the void volume and exhibited pronounced clustering in the ion mobility dimension, precluding reliable quantitation. In parallel, CCS-based mobility filtering supported suspect screening against an exposomic library (∼1100 entries) to expand detectable chemical space beyond targeted PFAS. Suspect screening yielded 49 non-PFAS candidates meeting accurate mass and CCS agreement criteria, and correlation analysis recapitulated expected co-exposure groupings among legacy PFCAs/PFSAs and structurally related suspect analytes. Collectively, these results establish a scalable, CCS-informed LC-IM-MS workflow for integrated targeted PFAS quantitation and exposomic suspect screening, enabling higher-powered association testing in the full set of PROMETHEUS samples and other large-scale human biomonitoring studies.


  • Maternal PFAS transfer through lactation: dolphin milk reveals routes of early-life exposure

    by Kara M. Joseph, Ashlee T. Falls, Sarah J. Rehm, James N. Dodds, Weihsueh A. Chiu, Michael L. Power, Erin S. Baker

    Per- and polyfluoroalkyl substances (PFAS) continue to increase in concentration and prevalence in the environment due to the creation of emerging PFAS and the lack of breakdown of legacy compounds. PFAS are known to both bioaccumulate and biomagnify; therefore, species higher on the food chain, such as marine mammals, are highly exposed to these chemicals. Although studies suggest that considerable maternal transfer of persistent organic pollutants occurs via lactation, data are still lacking on the temporal trends associated with PFAS exposure. In this study, we first optimized the extraction for PFAS from 5 and 1 mL of goat’s milk using a QuEChERS extraction method to account for precious breast milk samples that are often only available in small volumes. We then utilized a set of dolphin breastmilk samples from an individual mother across a 2-year lactation period to evaluate longitudinal trends in PFAS concentrations and profiles. Thirty PFAS were detected using a multidimensional platform combining liquid chromatography, ion mobility spectrometry, and mass spectrometry (LC-IMS-MS), and of these, 20 PFAS were detected continuously across the nursing window of 103–706 days. Quantitative analysis using LC-IMS-MS specifically showed concentrations of perfluorooctanesulfonic acid (PFOS) alone surpass weekly intake recommendations, allometrically scaled to dolphins, from the European Food Safety Authority and Food Standards Australia New Zealand by more than 25-fold. PFOS, however, decreased slightly over time, possibly due to transfer from feedings. Suspect screening and non-targeted analysis also identified 12 compounds including 2 long-chained perfluorosulfonic acids not traditionally evaluated in targeted analyses, as well as the PFOS precursors, perfluoroethylcyclohexane sulfonate (PFECHS) and 2-(N-ethylperfluorooctanesulfonamido) ethyl phosphate (SAmPAP). This study therefore suggests that breastmilk is a major contributor to early-life PFAS exposure for mammals, particularly to long-chained PFAS. Graphical Abstract


  • Top Cited Papers

    Evaluating Legacy and Emerging PFAS in Human Blood Collected from 2003 to 2021

    by Gregory P. Kudzin, James N. Dodds, Kaylie I. Kirkwood-Donelson, Adam Schiffenbauer, Kakali Sarkar, Payam Noroozi Farhadi, Frederick W. Miller, Dylan Johnson, Jessie Chappel, Alan K. Jarmusch, et al.

    Per- and polyfluoroalkyl substances (PFASs) are a class of manmade chemicals linked to numerous health outcomes including cancers and increased cholesterol. Consequently, legacy PFASs such as perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) have been voluntarily phased out of production within the United States since the early 2000s. However, as replacements, emerging PFASs have been introduced over the last 25 years. The presence and accumulation of these emerging PFASs remains largely unexplored due to the complexity of their identification and quantification. Here, we analyzed a unique set of serum samples (n = 156) collected from 2003 to 2021 consisting of three groups: an autoimmune proband, a healthy sibling, and an unrelated control. Quantitative analyses revealed no discernible link between PFAS exposure and autoimmune disease diagnosis; however, nontargeted analysis revealed concerning temporal trends in emerging replacement PFASs the significance of which is unknown. We detected a concerning increase in the chlorinated PFOS-replacement 9Cl-PF3ONS and polyfluoroalkyl phosphate species including 6:2 DiPAP and perfluoroalkyl phosphinic acids (PFPis) in human serum across the US since 2003. In addition, we documented the presence of a novel PFAS chloroperfluorononylphosphonic acid (Cl-PFNPA) in human serum. These analyses provide an assessment of how PFAS exposure has changed since 2003 while exploring potential linkages to autoimmune diseases.


  • Open Access

    Reference library for suspect screening of environmental toxicants using ion mobility spectrometry-mass spectrometry

    by Devin Teri, Noor A. Aly, James N. Dodds, Jian Zhang, Paul A. Thiessen, Evan E. Bolton, Kara M. Joseph, Antony J. Williams, Emma L. Schymanski, Ivan Rusyn, et al.

    Due to the potential health risks related to chemical exposure, rapidly assessing xenobiotic molecules in the environment and those already in the body is imperative. Targeted analytical methods coupling either gas or liquid chromatography with mass spectrometry (GC-MS or LC-MS) are commonly utilized in current exposure assessments. While these methods are accepted as the gold standard for exposure analyses, they often require multiple sample preparation steps and analysis times > 30 min. These limitations have resulted in an evolving interest in using ion mobility spectrometry and MS (IMS-MS), either with or without chromatography, to improve throughput and annotation confidence. To increase IMS-MS information availability for exposure studies, here we utilized drift tube IMS-MS to evaluate 4685 xenobiotic chemical standards from the Environmental Protection Agency Toxicity Forecaster (ToxCast) programme, including pesticides, industrial chemicals, pharmaceuticals, consumer products, and per- and polyfluoroalkyl substances. Collision cross section (CCS) and m/z values were detected for 2144 unique chemicals with high confidence and reproducibility (≤1% error intra-laboratory and ≤2% inter-laboratory), resulting in values for 4004 [M + H]+, [M+Na]+, [M-H]− and [M]•+ ion types. This multidimensional database therefore supports suspect screening for a wider range of environmental contaminants, faster exposure response times, and assessments of xenobiotic-disease connections.


  • Assessment of Variable Traveling Wave Profiles for Small-Molecule Applications in Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS)

    by James N. Dodds, Amie M. Solosky, Sadie M. Disselkoen, Kara M. Joseph, Erin S. Baker

    The MOBILion MOBIE system is a relatively new platform offering high ion mobility spectrometry (IMS) resolving power and resolution. While these advancements present encouraging opportunities for isomer separations and improved molecular annotation, previous studies have noted that collision cross section (CCS) values collected on the MOBIE and other traveling wave (TW) systems possess bias in calculated CCS values that limits the functionality of translating CCS libraries across multiple IMS platforms. Though these challenges persist, MOBILion recently released a software update (EyeOn v.2.3) that provides the capability of utilizing variable traveling wave profiles, which modulate the applied TW amplitude and frequency over the duration of each IMS scan to provide optimal transmission, IMS resolution, and scan speed. In this work, 5 variable TW profiles are assessed alongside a legacy "static" method for application toward future small-molecule workflows, tested herein with 3 model systems: per- and polyfluoroalkyl substances (PFAS), bile acids, and oxylipins. Using 3 primary evaluation metrics, including (1) ion transmission, (2) IMS resolution of isomeric species, and (3) relative ease of CCS conversion and mobility filtering, the collective results illustrate that the "Full" TW profile possesses many advantages when analyzing small molecules for nontargeted applications. Although the bias in TW-based CCS measurements vs previous DTIMS values remains, utilizing CCS values obtained with a consistent variable TW profile enables a linear calibration procedure, which facilitates routine mobility filtering of IMS-MS data by CCS and represents a needed improvement for streamlining both data acquisition and subsequent analysis.


  • Three Candidates, Two Peaks: Addressing Conflicting Assignments of Fentanyl Protomers with DMS-UVPD

    by Christian Ieritano, Allison N. Fry, James N. Dodds, Erin S. Baker, W. Scott Hopkins

    Fentanyl and its analogs, many of which share the piperidine-4-carboxamide core, consistently exhibit two distinct peaks when detected as the protonated ion on the various low-field IMS platforms (one major, one minor). These peaks, widely presumed to arise from prototropic isomers (i.e., protomers, which are isomers differing by the site of protonation), are generally agreed to originate from protonation at the piperidine nitrogen for the major feature, the most basic site in both the solution and gas phases. However, the origin of the minor feature remains unresolved, with prior studies attributing it to protonation either at the amide nitrogen or at the carbonyl oxygen, despite theoretical predictions placing the amide-N protomer roughly 35 kJ/mol higher in energy than its O-protonated counterpart. To resolve this, we combine differential mobility spectrometry (DMS), ultraviolet photodissociation (UVPD), tandem mass spectrometry (DMS-MS2/MS3), and quantum chemical calculations to interrogate the protomer landscape of ten fentanyl analogs. Mapping of fragmentation pathways using DMS-MS2/MS3, along with DMS-MS-UVPD supported by in silico vertical-gradient Franck-Condon (VG|FC) simulations of UV absorption spectra, indicates that the major feature arises from piperidine-N protonation while the minor feature corresponds to amide carbonyl-O protonation. Collision cross section (CCS) measurements further corroborate these assignments, with calculated CCSs matching experimental values within 1% (on average) for both the N- and O-protomers, while calculated CCSs for the amide-N protomers deviate by an average of 7%. Microsolvation studies reveal that serial solvation progressively narrows the energy gap between the piperidine-N and O-protomers via the formation of a solvent bridge between the two sites, suggesting that rapid desolvation during electrospray ionization can kinetically trap a fraction of the ensemble in the higher-energy O-protonated form.


  • Increasing Oligonucleotide Sequencing Information and Throughput with Ion Mobility Spectrometry–Mass Spectrometry

    by Jack P. Ryan, Gordon W. Slysz, Peter Rye, Sarah M. Stow, James N. Dodds, John Sausen, Erin S. Baker

    Synthetic oligonucleotides, such as antisense oligonucleotides or small interfering RNA, are small chain nucleic acid polymers that can be used therapeutically to control gene expression. Watson-Crick base pair interactions provide the primary mode of interaction between synthetic oligonucleotides and their target molecule, and this binding requires accurate, robust, and rapid sequence verification. The development of high-quality synthetic oligonucleotides and comprehensive analytical workflows for their evaluation is therefore essential. Herein, a platform coupling liquid chromatography, ion mobility spectrometry, collision-induced dissociation, and mass spectrometry (LC-IMS-CID-MS) was applied to facilitate oligonucleotide sequence confirmation. Using IMS, multiple charge states of the same oligonucleotide were mobility separated and analyzed simultaneously. Furthermore, all-ion fragmentation was implemented to provide sequence coverage for each charge state using fewer injections than current targeted multiple injection LC-MS methods. The results demonstrated herein denote sequence coverage is generally inversely proportional to oligonucleotide length (i.e., lower fidelity coverage for longer strands), with observed sequence coverages ranging between 40% and 80% for molecules comprised of 20-40 residues. To ease the burden of spectral interpretation and sequence determination for the LC-IMS-CID-MS data, an analysis workflow using the Pacific Northwest National Laboratories (PNNL) preprocessor and Agilent's BioConfirm software was developed.